MedTrace Logo

Patient-Reported Outcomes With LASIK:PROWL-1

NCT01526291 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 550

Last updated 2018-02-08

No results posted yet for this study

Summary

This study evaluates a questionnaire designed to measure satisfaction and ophthalmic-related quality of life (QOL)in up to 550 active duty subjects prior to and six months following state-of-the-art laser in situ keratomileusis (LASIK).

Conditions

  • Laser in Situ Keratomileusis

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • United States Naval Medical Center, San Diego

    collaborator FED

  • National Eye Institute (NEI)

    collaborator NIH

  • Food and Drug Administration (FDA)

    lead FED

Principal Investigators

  • Elizabeth M Hofmeister, MD · US Naval Medical Center, San Diego

  • Malvina Eydelman · US FDA

Eligibility

Min Age
21 Years
Max Age
84 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01526291 on ClinicalTrials.gov